Growth Metrics

Immuron (IMRN) Consolidated Net Income (2016 - 2024)

Immuron's quarterly Consolidated Net Income came in at $1660259165.7 billion in Q4 2024, up 80082653894883.1% year-on-year from N/an in Q1 2024, and up 80082653894883.1% quarter-over-quarter from -$2.1 million in Q4 2023.

Immuron has reported Consolidated Net Income for 9 years, with the latest figure at $1660259165.7 billion in Q4 2024.

  • For the quarter ending Q4 2024, Consolidated Net Income rose 80082653894883.1% year-over-year to $1660259165.7 billion; the trailing twelve-month figure through Sep 2025 stood at $1660259165.7 billion (up 80082653894883.1% YoY), and the FY2025 full-year result was -$3.4 million, up 25.69% from the prior year.
  • Consolidated Net Income for Q4 2024 stood at $1660259165.7 billion, up from -$2.1 million in the prior quarter.
  • The five-year high for Consolidated Net Income was $1660259165.7 billion in Q4 2024, with the low at -$2.1 million in Q4 2023.
  • Average Consolidated Net Income over 5 years is $276709860.9 billion, with a median of -$35292.1 recorded in 2021.
  • Year-over-year, Consolidated Net Income tumbled 15849.51% in 2023 and jumped 80082653894883.1% in 2024.
  • Tracing IMRN's Consolidated Net Income over 5 years: stood at -$57387.7 in 2020, then soared by 77.0% to -$13196.5 in 2021, then rose by 1.5% to -$12998.4 in 2022, then plunged by 15849.51% to -$2.1 million in 2023, then jumped by 80082653894883.1% to $1660259165.7 billion in 2024.
  • The last three Consolidated Net Income figures came in at $1660259165.7 billion (Q4 2024), -$2.1 million (Q4 2023), and -$1.2 million (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.99 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -8.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14.46 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.03 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.40 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 727.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 205.99 Mn
10 Immuron 1.27 Bn 1.27 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 1,660,259,165.67 Bn
Dec 31, 2023 -2.07 Mn
Jun 30, 2023 -1.24 Mn
Dec 31, 2022 -12,998.41
Dec 31, 2021 -13,196.46
Dec 31, 2020 -57,387.72
Dec 31, 2019 -15,212.27
Dec 31, 2018 -1.58 Mn
Dec 31, 2017 3.84 Mn
Dec 31, 2016 2.56 Mn
Jun 30, 2016 -3.28 Mn